0001093557-15-000226.txt : 20150717 0001093557-15-000226.hdr.sgml : 20150717 20150717190052 ACCESSION NUMBER: 0001093557-15-000226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150715 FILED AS OF DATE: 20150717 DATE AS OF CHANGE: 20150717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREGG TERRANCE H CENTRAL INDEX KEY: 0001236388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 15994764 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-07-15 0 0001093557 DEXCOM INC DXCM 0001236388 GREGG TERRANCE H 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 1 1 0 0 Executive Chairman Common Stock 2015-07-15 4 S 0 15000.0 81.6405 D 417139 I by Trust Common Stock 2015-07-17 4 S 0 35750.0 83.67 D 381389 I by Trust Common Stock 430626 D Common Stock 11461 I by IRA On December 12, 2014, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $81.32 to $82.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 5, 2015 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $83.67 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the July 17, 2015 closing of the exchange fund. By: Jess Roper For: Terrance H. Gregg 2015-07-17